PKM and breast carcinoma: Finally, immunohistochemical studies of human breast cancer showed that specimens lacking sCav-1 overexpress key enzymes of the glycolytic pathway, such as PKM2 and LDH32,33, thus generating, in the pre-metastatic niche, high quantities of energy metabolites (i.e. lactate and pyruvate) to feed the arriving DTCs.